Andrew Huberman· PhD
you know we might be satisfied with a person's apob being at the fifth percentile of the population which would be about 60 milligrams per deciliter
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
you know we might be satisfied with a person's apob being at the fifth percentile of the population which would be about 60 milligrams per deciliter
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
if your mace risk is less than 5% the thinking is you do not need to treat LDL or apob
fifth percentile from the framingham offspring study was is 62. i just in my mind keep keep 60. 10th percentile is about 70 20th percentiles 78 so i just think of 80 50th percentile is about 100 it's technically 97. 80th percentile 118. so i just kind of think of 120 95th percentile is 140.
so if you have somebody whose apob is 160 milligrams per deciliter there's a risk reduction that comes to lowering it from 160 to 100 and lowering it from 100 to 80 and lowering it from 80 to 60. what do we know about the risk reduction in lowering it say from 60 to 40 to 20 and I ask both what we could infer pharmacologically and non-pharmacologically in other words from the mendelian randomization versus the pharmacologic